International Society for Preventive Oncology
ISPO
Home -> Meetings -> Paris 2002 -> Abstracts -> Session 1202: Immunotherapy (Paris 2002)

Session 1202: Immunotherapy

Cochair(s): H de The, J Shay
Date: Tue 12 February 2002, Time: 17:00 - 18:30
Location: CIS Auditorium

Oral Presentations

Time Number Title / Authors / Affiliations
17:00 535 Analyses of retinoic or arsenic induced pml/rara degradation yields new insights into pml nuclear body formation and ligand-triggered nuclear receptor activation
J Zhu, V Lallemand-Breitenbach, H de The
CNRS UPR 9051 Hôpital St. Louis PARIS France
17:15 537 Lymphomas and autoimmunity
NR Rose
Johns Hopkins University, Baltimore, MD
17:45 538 Dendritic cell vaccines and the ontogeny of dendritic cells
C Gluckman, B Canque
Institut National de la Recherche Scientifique EPI-0013, and laboratoire d'Immunologie Cellulaire et Immunopathologie de l'Ecole Pratique des Hautes Etudes, hôpital Saint-Louis, Paris
17:30 558 The pathogenesis of autoimmunity
S Ikehara
Kansai Medical University, Osaka

This Page Last Updated

  • 06 Jul 2004

Site Contents

The Journal
CDP, a peer-refereed bi-monthly on predictive and preventive oncology
The Society
The International Society for Preventive Oncology
Meetings
Network and earn CME credits at our international symposia.

© 1993-2005 by the ISPO | About this Website | Contact Information